These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4856602)

  • 1. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH
    Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM; Nayak SK
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
    Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
    Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of antigens on transitional cell carcinoma with a xenogeneic antiserum.
    Bloom ET
    Natl Cancer Inst Monogr; 1978 Dec; (49):57-8. PubMed ID: 86168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific red cell adherence test applied to tumors of ureter and renal pelvis.
    Gruber MB; Becker SN; Warren MM; Rambo MJ; Davis CP
    Urology; 1982 Apr; 19(4):361-5. PubMed ID: 7072026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH; Castro A; Elliott A; Fraley EE
    Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
    [No Abstract]   [Full Text] [Related]  

  • 9. Staphylococcal protein A assay for detection of antibody directed at renal cancer cells.
    Leblanc PA; Taffet SM; Fried FA; Avis FP
    J Urol; 1979 Jun; 121(6):724-7. PubMed ID: 458941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
    Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
    Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
    Perlmann P; Troye M; Pape G; Blomgren H; Johansson B
    Urol Res; 1978; 6(4):207-9. PubMed ID: 741533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma.
    O'Toole C
    Int J Cancer; 1977 Mar; 19(3):324-31. PubMed ID: 844912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral cytotoxicity in human renal cell carcinoma.
    Hakala TR; Castro AE; Elliott AY; Fraley EE
    Invest Urol; 1974 Mar; 11(5):405-10. PubMed ID: 4592928
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 16. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
    Moroz C; Madgar I; Twig S; Lindner A; Many M
    Int J Cancer; 1982 Jun; 29(6):667-72. PubMed ID: 6980847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the red cell surface antigen to predict the malignant potential of transitional cell carcinoma of the ureter and renal pelvis.
    Hall L; Faddoul A; Saberi A; Edson M
    J Urol; 1982 Jan; 127(1):23-5. PubMed ID: 7057496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 19. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
    Schneider MU; Troye M; Paulie S; Perlmann P
    Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of monoclonal antibodies for the localization of tissue isoantigens A and B in transitional cell carcinoma of the upper urinary tract.
    Chapman CM; Allhoff EP; Proppe KH; Prout GR
    J Histochem Cytochem; 1983 Apr; 31(4):557-61. PubMed ID: 6827085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.